Missing messenger RNA fragments could be key to new immunotherapy for hard-to-treat brain tumors

A new study, led by researchers at Children’s Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that are missing in pediatric high-grade glioma tumors but not in normal brain tissues. Preclinical research indicates that these missing RNA fragments can make difficult-to-treat tumors more responsive to immunotherapy. The findings were recently published in the journal Cell Reports.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup